Associations Between Subclass Profile of IgG Response to Gluten and the Gastrointestinal and Motor Symptoms in Children With Cerebral Palsy.
Journal
Journal of pediatric gastroenterology and nutrition
ISSN: 1536-4801
Titre abrégé: J Pediatr Gastroenterol Nutr
Pays: United States
ID NLM: 8211545
Informations de publication
Date de publication:
01 09 2021
01 09 2021
Historique:
pubmed:
8
7
2021
medline:
3
9
2022
entrez:
7
7
2021
Statut:
ppublish
Résumé
Gastrointestinal problems are often seen in children with cerebral palsy, although the etiology and underlying mechanisms are not fully understood. Recent data point to significantly elevated levels of IgG antibody to dietary gluten in cerebral palsy independent of celiac disease, a gluten-mediated autoimmune enteropathy. We aimed to further characterize this antibody response by examining its subclass distribution and target reactivity in the context of relevant patient symptom profile. Study participants included children with cerebral palsy (n = 70) and celiac disease (n = 85), as well as unaffected controls (n = 30). Serum IgG antibody to gluten was investigated for subclass distribution, pattern of reactivity towards target proteins, and relationship with gastrointestinal symptoms and motor function. The anti-gluten IgG antibody response in the cerebral palsy cohort was constituted of all 4 subclasses. In comparison with celiac disease, however, IgG1, IgG2, and IgG3 subclasses were significantly lower, whereas the IgG4 response was significantly higher in cerebral palsy. Within the cohort of cerebral palsy patients, levels of anti-gluten IgG1, IgG3, and IgG4 were greater in those with gastrointestinal symptoms, and the IgG3 subclass antibody correlated inversely with gross motor function. The anti-gluten IgG antibodies targeted a broad range of gliadin and glutenin proteins. These findings reveal an anti-gluten IgG subclass distribution in cerebral palsy that is significantly different from that in celiac disease. Furthermore, the observed association between IgG subclass and symptom profile is suggestive of a relationship between the immune response and disease pathophysiology that may indicate a role for defects in gut immune and barrier function in cerebral palsy.
Identifiants
pubmed: 34231978
pii: 00005176-202109000-00018
doi: 10.1097/MPG.0000000000003181
pmc: PMC8380641
mid: NIHMS1706760
doi:
Substances chimiques
Immunoglobulin G
0
Glutens
8002-80-0
Gliadin
9007-90-3
Types de publication
Journal Article
Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
367-375Subventions
Organisme : NCATS NIH HHS
ID : UL1 TR000040
Pays : United States
Informations de copyright
Copyright © 2021 by European Society for Pediatric Gastroenterology, Hepatology, and Nutrition and North American Society for Pediatric Gastroenterology, Hepatology, and Nutrition.
Déclaration de conflit d'intérêts
The authors report no conflicts of interest.
Références
Korzeniewski SJ, Slaughter J, Lenski M, et al. The complex aetiology of cerebral palsy. Nat Rev Neurol 2018; 14:528–543.
CDC. Data and statistics for cerebral palsy. https://wwwcdcgov/ncbddd/cp/datahtml . Accessed December 8, 2020.
Graham HK, Rosenbaum P, Paneth N, et al. Cerebral palsy. Nat Rev Dis Primers 2016; 2:15082.
Sullivan PB. Gastrointestinal disorders in children with neurodevelopmental disabilities. Dev Disabil Res Rev 2008; 14:128–136.
Kuperminc MN, Stevenson RD. Growth and nutrition disorders in children with cerebral palsy. Dev Disabil Res Rev 2008; 14:137–146.
Alaedini A, Green PH. Narrative review: celiac disease: understanding a complex autoimmune disorder. Ann Intern Med 2005; 142:289–298.
Louka AS, Sollid LM. HLA in coeliac disease: unravelling the complex genetics of a complex disorder. Tissue Antigens 2003; 61:105–117.
Briani C, Samaroo D, Alaedini A. Celiac disease: from gluten to autoimmunity. Autoimmun Rev 2008; 7:644–650.
Stenberg R, Dahle C, Lindberg E, et al. Increased prevalence of anti-gliadin antibodies and anti-tissue transglutaminase antibodies in children with cerebral palsy. J Pediatr Gastroenterol Nutr 2009; 49:424–429.
Stenberg R, Dahle C, Magnuson A, et al. Increased prevalence of antibodies against dietary proteins in children and young adults with cerebral palsy. J Pediatr Gastroenterol Nutr 2013; 56:233–238.
Husby S, Foged N, Oxelius VA, et al. Serum IgG subclass antibodies to gliadin and other dietary antigens in children with coeliac disease. Clin Exp Immunol 1986; 64:526–535.
Saalman R, Dahlgren UI, Fallstrom SP, et al. IgG subclass profile of serum antigliadin antibodies and antibody-dependent cell-mediated cytotoxicity in young children with coeliac disease. Scand J Immunol 2001; 53:92–98.
Samaroo D, Dickerson F, Kasarda DD, et al. Novel immune response to gluten in individuals with schizophrenia. Schizophr Res 2010; 118:248–255.
Ellis HJ, Lozano-Sanchez P, Bermudo Redondo C, et al. Antibodies to wheat high-molecular-weight glutenin subunits in patients with celiac disease. Int Arch Allergy Immunol 2012; 159:428–434.
Hagberg B, Hagberg G, Olow I. The changing panorama of cerebral palsy in Sweden. IV. Epidemiological trends 1959–78. Acta Paediatr Scand 1984; 73:433–440.
Rosenbaum PL, Palisano RJ, Bartlett DJ, et al. Development of the gross motor function classification system for cerebral palsy. Dev Med Child Neurol 2008; 50:249–253.
Ivarsson A, Hernell O, Stenlund H, et al. Breast-feeding protects against celiac disease. Am J Clin Nutr 2002; 75:914–921.
Rubio-Tapia A, Hill ID, Kelly CP, et al. American College of G. ACG clinical guidelines: diagnosis and management of celiac disease. Am J Gastroenterol 2013; 108:656–676.
Aldrimer M, Ridefelt P, Rodoo P, et al. Reference intervals on the Abbot Architect for serum thyroid hormones, lipids and prolactin in healthy children in a population-based study. Scand J Clin Lab Invest 2012; 72:326–332.
Huebener S, Tanaka CK, Uhde M, et al. Specific nongluten proteins of wheat are novel target antigens in celiac disease humoral response. J Proteome Res 2015; 14:503–511.
Moeller S, Canetta PA, Taylor AK, et al. Lack of serologic evidence to link IgA nephropathy with celiac disease or immune reactivity to gluten. PLoS One 2014; 9:e94677.
Uhde M, Ajamian M, Caio G, et al. Intestinal cell damage and systemic immune activation in individuals reporting sensitivity to wheat in the absence of coeliac disease. Gut 2016; 65:1930–1937.
Altenbach SB, Chang HC, Yu XB, et al. Elimination of omega-1,2 gliadins from bread wheat (Triticum aestivum) flour: effects on immunogenic potential and end-use quality. Front Plant Sci 2019; 10:580.
Donnelly SC, Suligoj T, Ellis HJ, et al. Identification of coeliac disease triggering glutenin peptides in adults. Scand J Gastroenterol 2016; 51:819–826.
Tye-Din JA, Stewart JA, Dromey JA, et al. Comprehensive, quantitative mapping of T cell epitopes in gluten in celiac disease. Sci Transl Med 2010; 2:41ra51.
Sollid LM, Qiao SW, Anderson RP, et al. Nomenclature and listing of celiac disease relevant gluten T-cell epitopes restricted by HLA-DQ molecules. Immunogenetics 2012; 64:455–460.
Dorum S, Steinsbo O, Bergseng E, et al. Gluten-specific antibodies of celiac disease gut plasma cells recognize long proteolytic fragments that typically harbor T-cell epitopes. Sci Rep 2016; 6:25565.
Valenzuela NM, Schaub S. The biology of IgG subclasses and their clinical relevance to transplantation. Transplantation 2018; 102: (1S Suppl 1): S7–S13.
Halstensen TS, Hvatum M, Scott H, et al. Association of subepithelial deposition of activated complement and immunoglobulin G and M response to gluten in celiac disease. Gastroenterology 1992; 102:751–759.
Alaedini A, Latov N. Transglutaminase-independent binding of gliadin to intestinal brush border membrane and GM1 ganglioside. J Neuroimmunol 2006; 177:167–172.
Alaedini A, Okamoto H, Briani C, et al. Immune cross-reactivity in celiac disease: anti-gliadin antibodies bind to neuronal synapsin I. J Immunol 2007; 178:6590–6595.
Hadjivassiliou M, Boscolo S, Davies-Jones GA, et al. The humoral response in the pathogenesis of gluten ataxia. Neurology 2002; 58:1221–1226.
Davies AM, Sutton BJ. Human IgG4: a structural perspective. Immunol Rev 2015; 268:139–159.
Vidarsson G, Dekkers G, Rispens T. IgG subclasses and allotypes: from structure to effector functions. Front Immunol 2014; 5:520.
van der Neut Kolfschoten M, Schuurman J, Losen M, et al. Anti-inflammatory activity of human IgG4 antibodies by dynamic Fab arm exchange. Science 2007; 317:1554–1557.
Swisher JF, Haddad DA, McGrath AG, et al. IgG4 can induce an M2-like phenotype in human monocyte-derived macrophages through FcgammaRI. MAbs 2014; 6:1377–1384.
Collins AM, Jackson KJ. A temporal model of human IgE and IgG antibody function. Front Immunol 2013; 4:235.
Trampert DC, Hubers LM, van de Graaf SFJ, et al. On the role of IgG4 in inflammatory conditions: lessons for IgG4-related disease. Biochim Biophys Acta Mol Basis Dis 2018; 1864 (4 Pt B):1401–1409.
Perugino CA, Stone JH. IgG4-related disease: an update on pathophysiology and implications for clinical care. Nat Rev Rheumatol 2020; 16:702–714.
Kadhim H, Sebire G. Immune mechanisms in the pathogenesis of cerebral palsy: implication of proinflammatory cytokines and T lymphocytes. Eur J Paediatr Neurol 2002; 6:139–142.
Hagberg H, Mallard C, Ferriero DM, et al. The role of inflammation in perinatal brain injury. Nat Rev Neurol 2015; 11:192–208.
Khalif IL, Quigley EM, Konovitch EA, et al. Alterations in the colonic flora and intestinal permeability and evidence of immune activation in chronic constipation. Dig Liver Dis 2005; 37:838–849.
Brenchley JM, Douek DC. Microbial translocation across the GI tract. Annu Rev Immunol 2012; 30:149–173.
Ligaarden SC, Lydersen S, Farup PG. IgG and IgG4 antibodies in subjects with irritable bowel syndrome: a case control study in the general population. BMC Gastroenterol 2012; 12:166.
Volta U, De Giorgio R, Caio G, et al. Nonceliac wheat sensitivity: an immune-mediated condition with systemic manifestations. Gastroenterol Clin North Am 2019; 48:165–182.
Uhde M, Caio G, De Giorgio R, et al. Subclass profile of IgG antibody response to gluten differentiates non-celiac gluten sensitivity from celiac disease. Gastroenterology 2020; 159:1965–1967.